封面
市场调查报告书
商品编码
1491731

血管导管导引线市场规模、份额、成长分析、按产品、按涂层类型、按原材料、按最终用户 - 行业预测,2024-2031 年

Vascular Guidewires Market Size, Share, Growth Analysis, By Product, By Coating type(Coated ), By Raw Material, By End-user - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球血管导管导引线市场规模将为7.64亿美元,预测期间(2024-2031年)复合年增长率为5.10%,从2023年的8.0296亿美元成长至11.9541亿美元。

由于临床实践的进步和对微创手术的日益偏好,全球血管导管导引线市场显示出广阔的前景。医疗保健提供者越来越依赖导管导引线在手术过程中引导复杂的脉管系统,从而改善患者的治疗效果并降低与传统手术方法相关的风险。该市场的特点是竞争激烈,许多主要企业不断创新和扩大其产品范围,以满足医疗保健专业人员不断变化的需求。此外,严格的监管要求和品质保证措施仍然至关重要,以确保这些关键医疗设备的安全性和有效性。由于世界各地的医疗保健系统优先考虑效率和患者福祉,全球血管导管导引线市场在可预见的未来可能会稳定成长。

目录

介绍

  • 研究目的
  • 定义
  • 市场范围

调查方法

  • 资讯采购
  • 次要/一级资讯来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 市场概况展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 波特的分析

主要市场考察

  • 技术分析
  • 价格分析
  • 价值链分析
  • 市场生态系统
  • Start-Ups分析
  • 监管环境
  • 创新矩阵
  • 主要投资分析
  • 关键成功因素
  • 市场吸引力指数
  • 竞争程度

全球血管导管导引线市场:按产品

  • 市场概况
  • 冠状动脉导管导引线
  • 末梢血管导管导引线
  • 泌尿系统导管导引线
  • 神经血管导引线

全球血管导管导引线市场:按涂层类型

  • 市场概况
  • 涂层
    • 亲水涂层
    • 疏水涂层
  • 无涂层

全球血管导管导引线市场:依原料分类

  • 镍钛诺
  • 不銹钢
  • 其他原料

全球血管导管导引线市场:依最终用户分类

  • 市场概况
  • 医院
  • 门诊手术中心

血管导管导引线市场规模:按地区

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位(2023年)
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市场占有率(2023年)

主要企业简介

  • Abbott Laboratories(United States)
  • Boston Scientific Corporation(United States)
  • Terumo Corporation(Japan)
  • Medtronic plc(Ireland)
  • Cardinal Health, Inc.(United States)
  • Cook Medical LLC(United States)
  • B. Braun Melsungen AG(Germany)
  • Johnson & Johnson(United States)
  • CR Bard, Inc.(United States)
  • Olympus Corporation(Japan)
  • Teleflex Incorporated(United States)
  • Stryker Corporation(United States)
  • Merit Medical Systems, Inc.(United States)
  • Cordis Corporation(United States)
  • Biotronik SE & Co. KG(Germany)
  • ASAHI INTECC Co., Ltd.(Japan)
  • Vascular Solutions, Inc.(United States)
  • Integer Holdings Corporation(United States)
  • Penumbra, Inc.(United States)
  • Abbott Vascular(United States)
简介目录
Product Code: SQMIG35B2187

Global Vascular Guidewires Market size was valued at USD 764 million in 2022 and is poised to grow from USD 802.96 million in 2023 to USD 1195.41 million by 2031, at a CAGR of 5.10% during the forecast period (2024-2031).

The global market for vascular guidewires presents a promising prospect driven by advancements in clinical practices and a growing preference for minimally invasive techniques. Healthcare providers increasingly rely on these guidewires to navigate complex vascular systems during procedures, thereby improving patient outcomes and reducing risks associated with traditional surgical methods. This market is characterized by intense competition, with numerous key players consistently innovating and expanding their product offerings to meet the evolving needs of medical professionals. Furthermore, stringent regulatory requirements and quality assurance measures remain paramount, ensuring the safety and efficacy of these vital medical devices. As healthcare systems worldwide prioritize efficiency and patient well-being, the Global Vascular Guidewires market is poised for steady growth in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vascular Guidewires Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vascular Guidewires Market Segmental Analysis

The international Vascular Guidewires Market is segmented on the basis of software, coating kind, stop-user, and region. Based on application the market is segmented as Coronary Guidewires, Peripheral Guidewires, Urology Guidewires, and Neurovascular Guidewires. On the basis of coating type the market is segmented as Coated, and Non-Coated. Based on end-users, it is segregated into Hospitals and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Vascular Guidewires Market

The progression of specialized guidewires is heavily reliant on innovations in materials, layout, and production methods, all aimed at enhancing their flexibility and precision. These advancements play a crucial role in improving the performance of vascular guidewires, ultimately making them more effective and safer for intricate medical procedures. Consequently, these innovations are fueling market growth by meeting the increasing demand for enhanced medical devices.

Restraints in the Global Vascular Guidewires Market

Ensuring compliance with regulatory standards, including those established by the FDA in the United States and the CE marking in Europe, necessitates thorough testing and documentation procedures. This adherence can lead to prolonged approval processes and increased development costs for manufacturers, potentially impeding market expansion.

Market Trends of the Global Vascular Guidewires Market

Healthcare providers are customizing treatment approaches to individual patient needs, thereby shaping the evolution of vascular guidewires. Manufacturers are designing guidewires with adaptable features to meet patients' distinct anatomical and clinical needs, resulting in more efficient and patient-centered interventions. This trend mirrors the broader movement towards precision medicine in healthcare.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Start-up Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Market Attractive Index
  • Degree of Competition

Global Vascular Guidewires Market by Product

  • Market Overview
  • Coronary Guidewires
  • Peripheral Guidewires
  • Urology Guidewires
  • Neurovascular Guidewires

Global Vascular Guidewires Market by Coating Type

  • Market Overview
  • Coated
    • Hydrophilic coating
    • Hydrophobic coating
  • Non-Coated

Global Vascular Guidewires Market by Raw Material

  • Nitinol
  • Stainless Steel
  • Other Raw Material

Global Vascular Guidewires Market by End User

  • Market Overview
  • Hospitals,
  • Ambulatory Surgical Centres

Global Vascular Guidewires Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Abbott Laboratories (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical LLC (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • C. R. Bard, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cordis Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ASAHI INTECC Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vascular Solutions, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integer Holdings Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Penumbra, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Vascular (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments